Four years after starting semaglutide, patients maintained an average weight loss of 10% of their body weight, a peer-reviewed 2024 study funded by Novo Nordisk found
Diabetologia 57 (5), 950959
Together, they represent the kind of systems-based prevention that has a much stronger foundation than any single brain hack. The bottom line GLP-1 medications are interesting in the brain-health conversation because metabolism, vascular health, inflammation, and cognitive aging are connected
What Premium Healthcare Offers: Instead of extreme temperature therapies, we focus on: Medical-grade pain management solutions Physical therapy & rehabilitation Personalized recovery programs for athletes & active individuals For long-term pain relief and recovery, scientifically proven therapies work best
The hypothalamus and other brain areas that control appetite and energy balance have GLP-1 receptors, which these substances bind to a research claims that by affecting POMC neurons and inhibiting neuropeptide Y/agouti-related peptide (NPY/AgRP) pathways, activation of these receptors improves satiety signaling and decreases hunger []
